{"columns":[{"name":"Goal","type":"string"},{"name":"Target","type":"string"},{"name":"Indicator","type":"string"},{"name":"SeriesCode","type":"string"},{"name":"SeriesDescription","type":"string"},{"name":"GeoAreaCode","type":"string"},{"name":"GeoAreaName","type":"string"},{"name":"TimePeriod","type":"string"},{"name":"Value","type":"string"},{"name":"Time_Detail","type":"string"},{"name":"TimeCoverage","type":"string"},{"name":"UpperBound","type":"string"},{"name":"LowerBound","type":"string"},{"name":"BasePeriod","type":"string"},{"name":"Source","type":"string"},{"name":"GeoInfoUrl","type":"string"},{"name":"FootNote","type":"string"},{"name":"[Nature]","type":"string"},{"name":"[Reporting Type]","type":"string"},{"name":"[Units]","type":"string"}],"n_rows":3757,"rows_kept":3757,"cut":false,"text_format":"parquet-jsonl-2026-10-02","bounds":{"document_bytes":16777216,"package_text_limit_bytes":33554432,"package_text_slack_bytes":1024,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096,"vector_min":64,"vector_head_fixed":16,"vector_head_variable":64,"kv_value_chars":1048576,"nesting_max":64,"binary_text":true},"cells_cut":0,"cells_bad_utf8":0,"cells_raw":0,"cells_binary":0,"cells_binary_text":0,"cells_vector":0,"n_row_groups":1,"reader":"pyarrow 23.0.1, python 3.13","created_by":"DuckDB version v1.2.2 (build 7c039464e4)","schema":{"fields":[{"name":"Goal","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Target","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Indicator","type":"string","nullable":true,"metadata":null,"children":null},{"name":"SeriesCode","type":"string","nullable":true,"metadata":null,"children":null},{"name":"SeriesDescription","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoAreaCode","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoAreaName","type":"string","nullable":true,"metadata":null,"children":null},{"name":"TimePeriod","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Value","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Time_Detail","type":"string","nullable":true,"metadata":null,"children":null},{"name":"TimeCoverage","type":"string","nullable":true,"metadata":null,"children":null},{"name":"UpperBound","type":"string","nullable":true,"metadata":null,"children":null},{"name":"LowerBound","type":"string","nullable":true,"metadata":null,"children":null},{"name":"BasePeriod","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Source","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoInfoUrl","type":"string","nullable":true,"metadata":null,"children":null},{"name":"FootNote","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Nature]","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Reporting Type]","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Units]","type":"string","nullable":true,"metadata":null,"children":null}],"parquet":"required group field_id=-1 duckdb_schema {\n  optional binary field_id=-1 Goal (String);\n  optional binary field_id=-1 Target (String);\n  optional binary field_id=-1 Indicator (String);\n  optional binary field_id=-1 SeriesCode (String);\n  optional binary field_id=-1 SeriesDescription (String);\n  optional binary field_id=-1 GeoAreaCode (String);\n  optional binary field_id=-1 GeoAreaName (String);\n  optional binary field_id=-1 TimePeriod (String);\n  optional binary field_id=-1 Value (String);\n  optional binary field_id=-1 Time_Detail (String);\n  optional binary field_id=-1 TimeCoverage (String);\n  optional binary field_id=-1 UpperBound (String);\n  optional binary field_id=-1 LowerBound (String);\n  optional binary field_id=-1 BasePeriod (String);\n  optional binary field_id=-1 Source (String);\n  optional binary field_id=-1 GeoInfoUrl (String);\n  optional binary field_id=-1 FootNote (String);\n  optional binary field_id=-1 [Nature] (String);\n  optional binary field_id=-1 [Reporting Type] (String);\n  optional binary field_id=-1 [Units] (String);\n}\n"},"kv_metadata":[]}
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2011","12","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2012","30","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2013","48","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2014","55","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2015","58","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2016","62","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2017","65","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2018","64","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2019","65","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2020","68","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2021","62","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2022","62","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2023","69","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2016","95","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2022","95","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","232","Eritrea","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2008","4","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2009","6","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2010","10","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2011","15","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2012","19","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2013","26","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2014","32","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2015","38","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2016","41","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2017","45","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2018","48","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","233","Estonia","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2019","51","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2020","52","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2021","52","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2022","61","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","1","World","2023","65","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2009","0","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2010","3","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2011","10","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2012","20","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2013","31","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2013","87","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2020","98","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2014","45","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2015","56","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2016","63","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2017","65","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2018","67","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2019","68","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2020","67","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2021","64","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2022","64","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","2","Africa","2023","65","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","242","Fiji","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2010","92","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2014","49","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2015","65","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2016","62","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2017","63","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2018","64","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2017","85","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2019","89","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2020","86","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","246","Finland","2023","87","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2010","89","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2011","89","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2019","61","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2020","59","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2021","53","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2022","55","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","4","Afghanistan","2023","58","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2009","1","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2010","21","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2011","55","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2012","71","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2013","79","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2012","89","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2013","89","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2015","91","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","250","France","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2013","82","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2014","78","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2015","82","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2016","68","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2014","81","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2015","85","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2016","78","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2017","76","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2018","77","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2019","75","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2020","73","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2021","68","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2022","69","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","5","South America","2023","71","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2017","76","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2019","85","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2020","70","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2021","59","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2022","59","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","262","Djibouti","2023","72","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2020","92","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2021","89","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","8","Albania","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2008","42","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2009","51","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2010","51","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2011","51","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2012","51","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2013","53","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2014","53","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2015","63","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2016","64","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2017","70","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2018","70","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2019","70","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2020","73","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2021","70","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2022","72","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","9","Oceania","2023","69","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2010","1","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2011","6","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2012","10","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2013","13","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2014","24","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2015","51","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2016","62","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2017","66","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2018","68","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2019","71","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2020","67","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2021","66","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2022","69","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","11","Western Africa","2023","69","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2016","61","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2019","87","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2021","78","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2022","74","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","12","Algeria","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2008","10","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","266","Gabon","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2009","33","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2010","69","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2011","82","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2012","86","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2013","84","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2014","90","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2018","89","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2019","87","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2015","16","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2016","75","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2017","80","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2018","81","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2019","84","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2022","79","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","268","Georgia","2023","86","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2013","96","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2015","97","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2016","95","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2020","80","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","13","Central America","2023","80","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2010","3","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2011","16","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2012","27","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2013","52","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2014","68","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2019","87","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2021","78","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2022","75","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","270","Gambia","2023","80","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2012","25","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2020","98","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","275","State of Palestine","2023","87","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2015","69","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2016","73","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2017","74","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2018","76","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2019","76","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2020","75","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2021","72","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2022","72","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","14","Eastern Africa","2023","75","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2008","68","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2009","84","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2010","85","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2011","86","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2012","84","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2013","84","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2014","82","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2015","83","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2016","82","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2017","82","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2010","0","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2011","3","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2012","8","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2013","16","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2014","32","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2015","33","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2016","44","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2017","50","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2018","51","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2019","52","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2020","53","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2019","82","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2022","82","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","276","Germany","2023","82","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2012","43","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2013","89","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2015","88","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","288","Ghana","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2021","51","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2022","46","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","15","Northern Africa","2023","43","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2011","5","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2012","24","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2013","32","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2014","46","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2013","40","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2014","57","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2015","74","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2016","79","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2015","56","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2016","57","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2017","58","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2018","59","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2019","59","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2020","58","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2021","51","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2022","50","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","17","Middle Africa","2023","52","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2009","8","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2010","49","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2011","52","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2012","65","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2013","68","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2014","77","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2015","83","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2016","83","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2017","78","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2019","85","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2022","88","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","18","Southern Africa","2023","84","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2008","29","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2009","34","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2010","51","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2011","69","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2012","77","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2013","80","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2014","83","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2015","85","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2022","91","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","296","Kiribati","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2016","83","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2017","82","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2019","81","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2020","76","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2021","75","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2022","76","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","19","Americas","2023","76","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2022","95","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","20","Andorra","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2008","89","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2009","89","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2010","90","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2013","91","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2019","91","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","21","Northern America","2023","84","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2012","32","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2013","32","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2017","96","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2013","9","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2014","45","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2015","55","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2016","55","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2017","52","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2018","59","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2019","53","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2020","53","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2021","34","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","300","Greece","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","308","Grenada","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2022","24","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","24","Angola","2023","49","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2013","72","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2014","62","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","28","Antigua and Barbuda","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2009","0","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2010","0","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2011","0","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2012","2","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2013","3","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2014","12","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2015","11","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2016","13","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2017","24","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2018","30","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2019","42","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2020","47","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2021","49","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2022","48","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","29","Caribbean","2023","53","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2011","5","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2012","5","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2013","5","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2014","5","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2015","7","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2016","7","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2017","6","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2018","7","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2019","7","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2020","8","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2021","9","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2022","10","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","30","Eastern Asia","2023","10","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2014","64","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2017","96","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2022","83","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","31","Azerbaijan","2023","82","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2012","41","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2013","86","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2015","82","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2016","82","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2017","76","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2019","80","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2020","75","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2021","79","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2022","79","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","32","Argentina","2023","71","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2013","11","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2014","13","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2015","20","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2016","24","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2017","26","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2018","30","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2019","36","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2020","40","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2021","43","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2022","70","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","34","Southern Asia","2023","81","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2009","0","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2010","0","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2019","88","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2020","87","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2021","79","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","320","Guatemala","2023","87","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2011","0","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2012","0","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2013","0","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2014","8","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2015","8","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2016","13","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2017","19","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2018","22","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2019","25","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2020","27","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2021","22","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","324","Guinea","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2011","50","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2013","96","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2014","97","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2022","30","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","35","South-Eastern Asia","2023","44","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2008","91","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2009","91","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2010","91","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2011","91","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2012","91","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2013","91","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2014","91","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2020","89","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2022","95","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","328","Guyana","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2020","97","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","36","Australia","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2008","22","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2009","25","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2010","27","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2011","31","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2018","12","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2019","42","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2012","36","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2013","38","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2014","42","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2015","43","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2016","48","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2017","78","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2019","85","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2020","85","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2021","88","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2022","89","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2020","51","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2021","51","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2022","51","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","332","Haiti","2023","51","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2011","78","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","39","Southern Europe","2023","88","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","40","Austria","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2019","88","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2020","80","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2021","77","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2022","78","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","340","Honduras","2023","73","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2011","84","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2009","3","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2010","1","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2011","1","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2012","37","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2019","89","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2021","80","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2022","79","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","44","Bahamas","2023","81","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2008","14","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","348","Hungary","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2012","86","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2013","88","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","48","Bahrain","2023","98","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2014","90","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2015","91","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2017","88","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2021","92","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","352","Iceland","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2015","48","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2018","6","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2019","15","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2020","21","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2021","25","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2022","66","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","356","India","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2018","0","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2019","3","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2020","4","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2021","1","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2022","6","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","360","Indonesia","2023","31","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","50","Bangladesh","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2015","44","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2020","92","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2021","93","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","51","Armenia","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","364","Iran (Islamic Republic of)","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2009","75","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2010","78","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2011","81","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2012","84","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2013","87","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2014","90","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2015","97","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2018","89","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2017","33","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2018","33","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2019","37","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2020","0","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2021","0","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2022","0","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","368","Iraq","2023","14","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2010","43","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2011","90","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2012","91","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2013","91","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2016","91","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2019","86","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2020","86","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2021","85","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","372","Ireland","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2012","93","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2013","94","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2014","94","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","376","Israel","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2008","60","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2020","86","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","52","Barbados","2023","86","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2008","75","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2009","90","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2010","91","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2011","91","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2012","91","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2013","91","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2014","91","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","53","Australia and New Zealand","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2009","66","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2010","71","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2011","76","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2012","82","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2013","87","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2014","87","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2015","89","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2016","88","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2013","6","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2014","7","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2015","26","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2016","29","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2017","41","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2018","41","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2019","42","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2020","47","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2021","40","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2022","45","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","54","Melanesia","2023","38","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2012","93","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2013","93","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","380","Italy","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2014","2","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2015","70","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2016","80","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2017","81","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2018","83","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2019","78","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2020","71","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2021","64","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2022","68","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","384","Côte d'Ivoire","2023","79","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","56","Belgium","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2008","0","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","388","Jamaica","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2009","11","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2010","29","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2011","29","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2012","30","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2013","46","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2014","53","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2015","69","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2016","68","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2017","75","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2018","76","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2019","79","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2020","75","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2021","78","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2022","75","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","57","Micronesia","2023","82","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2009","0","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2010","0","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2011","0","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2012","0","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2013","0","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2014","0","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2015","0","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2016","0","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2017","0","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2018","0","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2019","0","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2020","0","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2021","21","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2022","47","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","61","Polynesia","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2012","0","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2013","11","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2014","13","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2015","20","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2016","24","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2017","28","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2018","32","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2019","38","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2020","42","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2021","45","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2022","70","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","62","Central and Southern Asia","2023","81","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2019","26","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","64","Bhutan","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2014","56","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","392","Japan","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2012","37","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2013","52","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2014","58","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2015","74","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2015","86","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2017","83","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2018","83","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2019","75","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2020","68","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2021","70","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2022","69","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","68","Bolivia (Plurinational State of)","2023","68","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2019","89","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2020","89","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2021","93","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","398","Kazakhstan","2023","98","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","70","Bosnia and Herzegovina","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","400","Jordan","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2011","85","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2012","82","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2012","52","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2013","72","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2016","91","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2022","68","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","72","Botswana","2023","81","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2010","24","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2011","82","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2012","88","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2013","94","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2016","84","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2017","82","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2018","80","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2019","78","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2021","69","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2022","72","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","76","Brazil","2023","74","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2013","77","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2014","84","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2016","83","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2017","78","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2018","89","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2020","92","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","404","Kenya","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","84","Belize","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2015","42","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2017","81","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2022","89","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","90","Solomon Islands","2023","81","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","408","Democratic People's Republic of Korea","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2015","97","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","96","Brunei Darussalam","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2010","69","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2011","94","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2012","94","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2013","94","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2015","90","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2018","97","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2020","97","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","410","Republic of Korea","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2019","88","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2020","85","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","100","Bulgaria","2023","87","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2016","14","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2020","86","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2021","40","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2022","57","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","104","Myanmar","2023","78","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2011","14","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2012","96","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2013","96","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2022","91","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","108","Burundi","2023","88","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","112","Belarus","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2014","94","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2015","68","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2017","81","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2018","83","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2019","88","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2020","86","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","414","Kuwait","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","116","Cambodia","2023","82","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2011","23","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2012","84","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2013","75","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2014","77","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2015","77","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2016","78","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2017","73","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2018","68","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2019","67","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2020","69","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2021","70","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2022","70","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","120","Cameroon","2023","75","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2008","42","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2009","50","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2010","58","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2017","88","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","417","Kyrgyzstan","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2011","66","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2012","73","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2013","79","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2014","79","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2016","80","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2017","81","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2018","81","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2019","84","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2020","84","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2021","84","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2014","60","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2015","74","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2016","78","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2017","82","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","124","Canada","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","132","Cabo Verde","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2019","81","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2020","77","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2021","74","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2022","78","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","418","Lao People's Democratic Republic","2023","81","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2008","3","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2009","11","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2010","35","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2011","60","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2012","71","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2013","76","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2014","80","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2015","82","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2016","79","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2017","78","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2018","78","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2019","77","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2020","74","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2021","71","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2022","73","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","419","Latin America and the Caribbean","2023","73","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2011","8","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2012","47","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2013","23","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2014","45","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2015","44","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2016","43","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2017","40","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2017","82","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2019","82","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2020","74","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2021","70","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2022","70","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","422","Lebanon","2023","65","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2015","29","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2017","87","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2018","87","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2019","87","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2020","87","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2021","87","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","426","Lesotho","2023","87","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2011","76","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2012","55","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2013","87","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2014","84","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2015","85","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2018","40","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2019","40","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2020","40","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2021","40","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2022","40","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","140","Central African Republic","2023","40","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2008","0","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2009","2","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2010","2","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2011","5","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2012","5","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2016","84","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2017","87","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2019","84","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2021","92","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","428","Latvia","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2014","25","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2015","36","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2016","73","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2017","78","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2018","78","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2019","68","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2020","65","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2021","65","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2022","74","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","430","Liberia","2023","80","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2010","2","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2011","8","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2012","21","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2013","28","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2014","49","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2015","56","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2016","63","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2017","72","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2018","72","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2019","72","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2020","71","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2021","70","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2022","71","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","432","Landlocked developing countries (LLDCs)","2023","74","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2013","11","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2014","13","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2015","18","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2016","21","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2017","24","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2018","27","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2019","31","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2020","34","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2021","36","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2022","53","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","142","Asia","2023","62","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2012","9","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2013","13","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2014","14","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2015","17","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2016","23","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2017","73","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2018","72","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2019","73","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2020","72","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","143","Central Asia","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","144","Sri Lanka","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2008","1","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2009","35","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2010","34","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2011","44","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2012","50","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2013","53","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2014","56","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2015","58","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2016","60","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2014","39","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2015","71","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2018","72","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2017","67","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2018","65","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2019","66","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2020","55","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2021","55","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2022","55","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","145","Western Asia","2023","54","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2019","73","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2020","73","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2021","73","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2022","73","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","434","Libya","2023","73","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2016","82","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2017","82","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2019","82","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2022","81","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","148","Chad","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2008","11","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2009","17","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2010","37","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2011","40","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2012","42","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2013","43","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","440","Lithuania","2023","82","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2008","86","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2009","86","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2010","86","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2011","86","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2012","95","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2013","95","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2016","95","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2014","44","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2015","44","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2016","54","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2017","68","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2018","75","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2019","80","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2020","80","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2021","81","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2022","83","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","150","Europe","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","442","Luxembourg","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2009","2","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2010","3","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2011","6","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2012","6","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2013","6","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2014","6","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2015","7","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2016","26","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2017","45","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2018","59","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2019","70","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2013","76","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2014","68","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2015","62","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2016","65","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2017","62","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2018","73","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2019","69","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2020","67","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2021","57","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2022","57","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2020","71","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2021","72","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2022","76","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","151","Eastern Europe","2023","77","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2011","54","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2012","82","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2013","79","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","450","Madagascar","2023","73","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2013","89","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2014","87","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2015","88","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2016","83","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2017","88","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2021","93","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","454","Malawi","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2015","90","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2020","89","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2021","92","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","152","Chile","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2008","9","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2009","18","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2010","82","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2011","87","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2012","89","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2013","90","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2015","90","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2016","91","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2021","76","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2022","86","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","458","Malaysia","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2022","89","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","154","Northern Europe","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2008","24","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2009","39","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2010","77","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2011","78","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2012","83","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2013","84","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2014","83","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","462","Maldives","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2011","56","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2012","58","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2013","59","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2014","57","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2015","65","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2016","74","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2017","74","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2018","73","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2019","74","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2020","66","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2021","77","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2022","77","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","466","Mali","2023","77","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2015","84","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2016","84","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2017","84","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2019","84","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2020","85","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2021","85","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","155","Western Europe","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","470","Malta","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","156","China","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2010","22","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2011","46","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2012","84","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2013","87","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2015","91","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2016","89","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2020","89","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2021","84","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2013","1","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2014","71","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2015","71","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2016","71","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2017","72","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2018","72","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2019","76","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2021","77","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","478","Mauritania","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","170","Colombia","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","174","Comoros","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2016","10","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2017","84","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2020","86","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","480","Mauritius","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2008","14","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2009","46","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2010","92","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2012","10","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2013","85","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2014","85","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2016","67","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2017","66","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2018","73","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2013","84","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2014","94","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2019","86","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2020","77","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","484","Mexico","2023","78","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2019","68","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2020","71","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2021","75","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2022","76","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","178","Congo","2023","76","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2011","3","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2012","23","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2013","34","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2014","48","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2015","64","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2016","66","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2017","69","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2018","70","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2019","72","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2020","69","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2021","63","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2022","64","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","180","Democratic Republic of the Congo","2023","59","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","492","Monaco","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2017","13","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2018","26","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2019","49","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2020","92","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","496","Mongolia","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2013","1","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2014","28","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2015","72","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2016","77","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2017","79","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2018","85","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2019","80","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2020","72","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2021","78","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2022","79","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2022","43","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","184","Cook Islands","2023","77","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","498","Republic of Moldova","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","499","Montenegro","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2010","1","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2011","23","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2012","72","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2013","80","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2014","90","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2020","98","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","504","Morocco","2023","98","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2013","45","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2009","48","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2010","94","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2011","68","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2012","89","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2013","94","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2014","83","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2017","96","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2014","76","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2016","80","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2017","80","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2018","80","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2019","80","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2020","68","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2021","56","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2022","55","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","508","Mozambique","2023","55","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2021","87","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","188","Costa Rica","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","512","Oman","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2008","39","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2009","43","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2010","56","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2011","58","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2012","59","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2013","60","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2014","61","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2015","61","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2021","75","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","191","Croatia","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2016","68","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2017","76","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2018","81","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2019","84","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2020","81","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2022","83","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","513","Europe and Northern America","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2008","37","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2009","40","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2010","52","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2011","62","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2012","63","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2013","64","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2014","64","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2015","65","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2016","71","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2017","78","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2019","85","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2008","0","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2009","3","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2010","5","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2011","10","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2012","14","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","192","Cuba","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2013","22","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2014","28","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2015","35","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2016","38","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2017","41","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2018","44","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2019","47","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2020","49","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2021","49","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2022","58","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","515","Developing regions","2023","63","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2015","81","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2016","81","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2017","81","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2015","81","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2016","84","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2018","81","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2019","81","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2020","81","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2021","81","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2022","81","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","196","Cyprus","2023","74","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2010","1","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2011","7","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2017","67","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2018","61","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2019","57","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2020","78","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2021","79","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","516","Namibia","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2012","16","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2013","29","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2014","48","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2015","59","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2016","69","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2017","73","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2018","74","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2019","74","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2020","72","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2021","68","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2022","68","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","199","Least Developed Countries (LDCs)","2023","69","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2009","0","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2010","3","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2011","12","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2012","22","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2013","34","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2014","47","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2015","60","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2016","66","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2017","68","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2021","59","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","520","Nauru","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2015","5","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2016","46","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2017","80","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2019","83","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2020","80","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2021","84","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2022","83","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","524","Nepal","2023","88","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2010","96","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2012","96","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2013","96","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2021","93","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","528","Netherlands (Kingdom of the)","2023","88","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2008","0","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2009","0","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2010","1","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2011","1","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2012","1","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2013","7","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2014","8","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2015","26","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2016","29","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2017","41","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2018","41","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2019","41","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2020","46","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2021","41","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2022","46","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","543","Oceania (exc. Australia and New Zealand)","2023","40","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2018","70","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2019","71","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2020","69","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2021","66","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2022","67","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","202","Sub-Saharan Africa","2023","68","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2021","2","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2022","42","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","548","Vanuatu","2023","63","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2009","87","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2010","89","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","203","Czechia","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2011","36","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2012","67","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2013","70","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2013","93","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2019","91","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2020","92","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2022","86","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","554","New Zealand","2023","86","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2011","61","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2014","69","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2015","72","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2016","73","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2017","72","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2018","72","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2019","71","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2020","70","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2021","70","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2022","69","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","204","Benin","2023","69","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2009","86","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2010","88","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2011","90","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2012","93","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2013","90","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2015","91","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","208","Denmark","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2020","92","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2021","87","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","558","Nicaragua","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","212","Dominica","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2014","27","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2015","22","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2014","13","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2015","49","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2016","76","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2017","85","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2018","79","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2019","81","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2020","81","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","562","Niger","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2015","36","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2016","49","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2017","53","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2018","59","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2019","64","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2020","60","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2021","60","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2022","60","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","566","Nigeria","2023","60","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","570","Niue","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2008","86","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2009","91","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2010","91","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2012","93","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2013","93","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2014","91","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2016","30","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2017","64","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2018","66","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2019","67","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2020","69","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2021","76","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2022","73","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","214","Dominican Republic","2023","86","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2022","95","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","578","Norway","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2010","70","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2011","63","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2012","60","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2013","61","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2014","64","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2015","67","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2016","63","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2017","65","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2018","67","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2019","73","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2021","70","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2010","17","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2011","71","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2012","94","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2013","90","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2014","86","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2015","81","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2016","84","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2017","84","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2018","85","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2019","83","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2020","76","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2021","62","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2022","71","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","218","Ecuador","2023","71","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2010","66","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2012","94","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2014","88","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2022","65","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","583","Micronesia (Federated States of)","2023","73","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2009","49","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2010","24","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2011","35","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2012","46","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2013","38","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2014","29","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2015","75","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2016","65","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2017","96","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2018","87","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2021","92","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","222","El Salvador","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2017","72","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2018","67","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2019","63","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2020","38","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2021","61","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2022","29","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","584","Marshall Islands","2023","62","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2008","7","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2009","18","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2010","45","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2011","61","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2012","82","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2013","93","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2019","74","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2020","75","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2021","77","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2022","82","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","585","Palau","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2013","65","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2014","68","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2016","78","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2017","82","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2019","83","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","586","Pakistan","2023","86","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2010","48","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2011","63","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2012","76","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2013","88","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2014","91","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2018","97","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2020","74","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2021","87","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","591","Panama","2023","69","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2015","20","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2016","20","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2017","36","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2018","35","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2019","35","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2020","41","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2021","34","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2022","38","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","598","Papua New Guinea","2023","29","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2012","82","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2013","90","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2014","86","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2015","90","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2019","89","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2021","62","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2022","74","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","600","Paraguay","2023","77","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2009","9","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2010","73","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2011","82","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2012","89","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2013","85","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2014","86","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2015","90","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2016","86","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2017","84","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2019","80","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2020","74","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2021","75","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2022","71","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","604","Peru","2023","80","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2014","35","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2015","20","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2016","40","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2017","38","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2018","49","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2019","61","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2020","76","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2021","61","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2022","81","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","608","Philippines","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2018","60","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2019","89","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2020","88","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2021","88","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2022","88","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","616","Poland","2023","88","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2016","73","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2017","96","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2020","98","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","620","Portugal","2023","98","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2015","10","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2016","83","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2017","79","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2019","78","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2020","74","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2021","67","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2022","74","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","624","Guinea-Bissau","2023","74","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","626","Timor-Leste","2023","56","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2010","97","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2014","94","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2020","98","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","634","Qatar","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2019","88","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2020","85","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2021","85","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","642","Romania","2023","78","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2016","35","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2017","70","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2019","85","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2020","87","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2021","89","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","643","Russian Federation","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2010","97","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2011","97","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2018","97","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2021","88","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","646","Rwanda","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","659","Saint Kitts and Nevis","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","662","Saint Lucia","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","670","Saint Vincent and the Grenadines","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2016","53","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2017","56","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2018","58","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2019","76","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2022","80","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","674","San Marino","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","678","Sao Tome and Principe","2023","86","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","682","Saudi Arabia","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2014","81","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2015","89","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","686","Senegal","2023","80","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2018","67","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2020","88","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2021","89","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","688","Serbia","2023","82","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2018","16","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","690","Seychelles","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2011","75","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2014","83","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2015","86","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2016","84","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","694","Sierra Leone","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2009","17","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2010","22","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2011","40","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2012","52","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2013","60","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2014","68","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2015","75","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2016","78","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2017","83","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2019","84","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2020","87","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2021","88","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","702","Singapore","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2017","96","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","703","Slovakia","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","704","Viet Nam","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2015","49","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2016","49","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2017","55","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2018","60","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2019","65","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2020","70","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2021","58","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2022","61","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","705","Slovenia","2023","58","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","706","Somalia","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2009","10","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2010","58","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2011","62","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2012","75","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2013","77","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2014","85","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2015","85","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2016","82","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2017","78","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2018","83","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2019","86","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2021","87","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2022","89","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","710","South Africa","2023","84","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2012","21","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2013","95","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2014","91","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2015","87","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2018","89","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2020","86","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2021","88","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","716","Zimbabwe","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2008","0","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2009","1","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2010","1","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2011","3","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2012","5","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2013","8","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2014","13","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2015","18","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2016","24","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2017","34","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2018","37","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2019","44","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2020","48","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2021","47","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2022","49","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","722","Small island developing States (SIDS)","2023","51","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2017","88","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2021","92","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","724","Spain","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","728","South Sudan","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2013","30","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2014","97","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2021","85","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2022","69","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","729","Sudan","2023","52","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","740","Suriname","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2008","0","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2009","17","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2010","16","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2011","23","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2012","29","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2013","34","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2014","44","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2015","45","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2016","52","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2017","58","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2018","58","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2019","59","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2020","54","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2021","53","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2022","50","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","747","Northern Africa and Western Asia","2023","49","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2014","67","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2015","90","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2017","87","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2019","87","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2021","63","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","748","Eswatini","2023","66","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2008","60","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2015","97","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2018","97","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2020","97","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","752","Sweden","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2009","0","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2010","0","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2011","3","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2012","3","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2013","3","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2014","6","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2015","7","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2016","9","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2017","11","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2018","13","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2019","14","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2020","17","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2021","15","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2022","20","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","753","Eastern and South-Eastern Asia","2023","27","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2008","13","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2009","25","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2010","37","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2011","50","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2012","62","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2013","75","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2014","80","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2016","80","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2017","84","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2019","84","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2020","86","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2021","88","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2022","89","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","756","Switzerland","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","760","Syrian Arab Republic","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","762","Tajikistan","2023","31","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","764","Thailand","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2014","25","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2015","77","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2016","82","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2017","83","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2018","81","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2019","83","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2022","82","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","768","Togo","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2021","67","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2022","67","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","776","Tonga","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2012","39","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2013","80","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2016","91","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","780","Trinidad and Tobago","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2010","94","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2012","96","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2017","96","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2020","84","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2022","95","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","784","United Arab Emirates","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2020","87","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","788","Tunisia","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2009","97","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2010","93","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2015","97","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2017","96","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2018","97","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2022","95","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","792","Türkiye","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2020","23","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","795","Turkmenistan","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2022","83","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","798","Tuvalu","2023","98","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2014","60","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2015","64","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2016","77","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2020","89","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","800","Uganda","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","804","Ukraine","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2020","30","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2021","53","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2022","56","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","807","North Macedonia","2023","56","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","818","Egypt","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2010","89","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2011","90","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2013","93","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2019","91","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","826","United Kingdom of Great Britain and Northern Ireland","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2013","80","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2020","89","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2021","89","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","834","United Republic of Tanzania","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2008","93","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2009","93","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2010","93","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2011","94","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","840","United States of America","2023","84","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2014","91","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2015","91","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2016","91","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2019","91","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2021","66","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","854","Burkina Faso","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2010","91","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2012","93","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2013","93","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","858","Uruguay","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","860","Uzbekistan","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2015","24","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2016","7","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2017","0","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2018","0","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2019","0","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2020","0","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2021","0","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2022","0","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","862","Venezuela (Bolivarian Republic of)","2023","0","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2021","3","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2022","36","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","882","Samoa","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2011","41","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2012","67","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2013","71","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2014","69","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2015","63","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2016","62","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2017","58","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2018","51","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2019","58","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2020","55","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2021","55","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2022","57","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","887","Yemen","2023","45","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2014","77","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2015","81","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2019","89","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2020","85","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2021","89","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2022","78","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","894","Zambia","2023","78","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","226","Equatorial Guinea","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_PCV3","Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)","231","Ethiopia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"The PCV3 vaccine has not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]